“Signing a GPO contract is certainly a key milestone for us as it validates the hospital market demand for our solutions. But being the sole source supplier to one the largest IDNs in the US market is really a landmark for
Every year, approximately 100 million patients, including children, receive neuromuscular blocking drugs as part of anesthesia to facilitate endotracheal intubation and optimize surgical conditions. These medications paralyze muscles required for breathing; hence, accurate monitoring during surgery to secure each patient’s individual dose is paramount for a safe and timely recovery.
Senzime’s TetraGraph is a state-of-the-art quantitative train-of-four (TOF) neuromuscular monitoring system used by anesthesiologists at hundreds of leading hospitals worldwide. Its proprietary technology helps anesthesiologists accurately select the right dose of neuromuscular blocking drugs and their antagonists allowing for patients to safely recover following surgery.
© Modular Finance, source